Cellular Dynamics International (CDI) reported the merger of sister companies Stem Cell Products and iPS Cells with CDI. The merged entity will continue to operate as Cellular Dynamics International.
According to the company, the merger positions CDI as a leader in the stem cell research tools and personalized bio-banking industries by placing the intellectual property and commercial, research, and production capabilities of the predecessor companies under a unified management team.
CDI was founded in 2004 by James Thomson, Craig January, Timothy Kamp, and Igor Slukvin, professors at the University of Wisconsin-Madison. The firm is currently commercializing pluripotent stem cell-derived cardiomyocytes and a variety of other cell types for use by the pharmaceutical industry.